Description: Left atrial appendage occlusion (LAAO) has become an important alternative for stroke prevention in patients with atrial fibrillation who are not ideal candidates for long-term anticoagulation. However, determining the optimal antithrombotic strategy following the procedure remains a complex clinical challenge. This presentation will explore current recommendations for post-LAAO antithrombotic therapy, the comparative use of different anticoagulant and antiplatelet options, and the role of imaging in long-term management. Evidence from recent studies will be discussed to help guide clinical decision-making and improve patient outcomes.  

Microsoft Teams Meeting link to join the live session: Join the meeting now

Speaker: Kans Lewis, PharmD, PGY1 Pharmacy Resident – Aurora Health Care Metro, Inc  

Objectives: ​​ 

  • Identify the initial recommendations for antithrombotic therapy following left atrial appendage occlusion (LAAO) 
  • Compare the efficacy and safety of direct oral anticoagulants (DOACs), warfarin, and antiplatelet therapy in post-LAAO patients  
  • Examine the role of transesophageal echocardiography (TEE) in monitoring for device-related thrombus after LAAO 
  • Apply evidence-based strategies to optimize antithrombotic therapy selection in post-LAAO patients 

Target Audience:​ Advocate Pharmacists, Physicians, Nurses, and other interested healthcare professionals

Disclosure:​ The planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. 

Session date: 
04/25/2025 - 12:00pm to 1:00pm CDT
Location: 
ASLMC Stiemke Auditorium and Virtual via Teams
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™
  • 1.00 Continuing Nursing Education (CE)
    Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.00 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.
  • 1.00 Continuing Pharmacy Education (CPE)
    Aurora Health Care Department of Pharmacy Services is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Please login or register to take this course.